Observational studyThe oncologist2025

ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC.

Joyce Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.